Quick Takeaways
- Laurie Stelzer has 7 issuer positions tracked on this page.
- Estimated disclosed ownership value: $6,038,454.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Laurie Stelzer
- Location
- Waltham, MA
- Summary
- The estimated net worth of Laurie Stelzer is at least $6,038,454 dollars as of 22 Jan 2026. Laurie Stelzer is the Chief Financial Officer of Mirati Therapeutics, Inc. and owns shares of Mirati Therapeutics, Inc. stock worth about $6.04M.
- Signature
- /s/ Richard Bartram, attorney-in-fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Laurie Stelzer and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: Mirati Therapeutics, Inc. ($6,038,454).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Laurie Stelzer
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| MRTX | Mirati Therapeutics, Inc. | Chief Financial Officer | $6,038,454 | 09 Aug 2023 | ||
| ARNA | ARENA PHARMACEUTICALS INC | EVP & Chief Financial Officer | 11 Mar 2022 | |||
| MBX | MBX Biosciences, Inc. | Director | 20 Jan 2026 | |||
| PMVP | PMV Pharmaceuticals, Inc. | Director | 05 Jun 2025 | |||
| SION | Sionna Therapeutics, Inc. | Director | 12 Jun 2025 | |||
| SYRE | Spyre Therapeutics, Inc. | Director | 29 May 2025 | |||
| SURF | Surface Oncology, Inc. | Director | 08 Jun 2022 |
Insider Transactions Reported by Laurie Stelzer:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.